Document is current
Any future updates will be listed below
-
Authors
Higashikawa, Kei
Uehara, Riho
Horiguchi, Sawako
Shibata, Yuki
Okubo, Naoto
Mizuno, Yuki
Yasui, Hironobu
Ohnishi, Shunsuke
Takeda, Hiroshi
Kuge, Yuji https://orcid.org/0000-0002-0483-9706
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (Grants-in-Aid for Scientific Research (Grant number: 19K17255))
- License Information
-
More Information
Article History
Received: 18 July 2024
Revised: 30 October 2024
Accepted: 4 November 2024
First Online: 13 November 2024
Declarations
:
: Yuji Kuge, Hokkaido University, and Health Sciences University of Hokkaido had patent rights for [<sup>123</sup>I]IIMU, but the patent rights has been expired. Yuji Kuge has received grants from Nihon Medi-Physics Co.,Ltd., grants from ATOX Co.,Ltd., grants from Sumitomo Heavy Industries, Ltd., grants from Advanced Medical Science-Planning, Inc, personal fees for consultation from Ono Pharmaceutical Co., Ltd., personal fees for consultation from Novartis Pharma K.K., outside the submitted work. Kei Higashikawa is presently an employee of CHUGAI PHARMACEUTICAL CO., LTD. There are no other potential conflicts of interest relevant to this article.
